ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 957,57
0,54%
Dow Jones
38 675,68
1,18%
DAX
18 001,60
0,54%
Brent Oil
82,765
0,00%
Bitcoin
63 339,71
-0,87%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Soleno Therapeutics Inc (SLNO)

  7. Soleno Therapeutics Inc (SLNO) Actualités

SLNO Soleno Therapeutics Inc

45,12
-4,11 (-8,35%)
04 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Soleno Therapeutics Inc SLNO NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
-4,11 -8,35% 45,12 00:14:04
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
47,14 44,98 48,49 45,12 49,23
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
03/5/202404:32GLOBESoleno Therapeutics Announces Pricing of Approximately $138..
02/5/202422:01GLOBESoleno Therapeutics Announces Proposed Public Offering of..
30/4/202414:00GLOBESoleno Therapeutics Announces Peer-Reviewed Publication of..
29/4/202414:00GLOBESoleno Therapeutics Receives Breakthrough Therapy..
19/4/202422:05GLOBESoleno Therapeutics Announces Inducement Grants Under Nasdaq..
08/3/202422:05GLOBESoleno Therapeutics Announces Inducement Grants Under Nasdaq..
07/3/202412:06EDGAR2Form 8-K - Current report
06/3/202422:05GLOBESoleno Therapeutics Provides Corporate Update and Reports..
22/2/202414:00GLOBESoleno Therapeutics to Present at the TD Cowen 44th Annual..
31/1/202422:19EDGAR2Form S-8 - Securities to be offered to employees in employee..
30/1/202422:57EDGAR2Form 8-K - Current report
29/1/202423:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/1/202423:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/1/202423:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/1/202422:05GLOBESoleno Therapeutics Announces Inducement Grants Under Nasdaq..
24/1/202414:00GLOBESoleno Therapeutics Strengthens Leadership Team with Key..
17/1/202422:06EDGAR2Form S-8 - Securities to be offered to employees in employee..
08/1/202423:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202423:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202423:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202422:16EDGAR2Form 8-K - Current report
05/1/202414:00GLOBESoleno Therapeutics Announces Inducement Grants Under Nasdaq..
02/1/202422:06EDGAR2Form S-3ASR - Automatic shelf registration statement of..
16/12/202300:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/12/202301:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/12/202323:09EDGAR2Form 144 - Report of proposed sale of securities
14/12/202303:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/12/202303:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202322:53EDGAR2Form 144 - Report of proposed sale of securities
13/12/202322:46EDGAR2Form 144 - Report of proposed sale of securities
13/12/202300:17EDGAR2Form 144 - Report of proposed sale of securities
12/12/202301:05EDGAR2Form 144 - Report of proposed sale of securities
05/12/202302:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202302:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202302:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/12/202303:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/12/202303:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/12/202303:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/11/202322:05GLOBESoleno Therapeutics Announces Inducement Grants Under Nasdaq..
07/11/202314:00GLOBESoleno Therapeutics Provides Corporate Update and Reports..
06/11/202314:00GLOBESoleno Therapeutics Announces Peer-Reviewed Publication of..
01/11/202305:15EDGAR2Form EFFECT - Notice of Effectiveness
20/10/202322:32EDGAR2Form S-3 - Registration statement under Securities Act of..
16/10/202322:30EDGAR2Form SC 13D/A - General statement of acquisition of..
12/10/202322:05EDGAR2Form SC 13G - Statement of acquisition of beneficial..
11/10/202322:30EDGAR2Form SC 13D/A - General statement of acquisition of..
10/10/202322:30EDGAR2Form SC 13G - Statement of acquisition of beneficial..
05/10/202300:16GLOBECorrecting & Replacing -- Soleno Therapeutics Announces DCCR..
04/10/202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202322:05GLOBESoleno Therapeutics Announces DCCR Data Presentation at the..

Dernières Valeurs Consultées

NASDAQ
SLNO
Soleno Therapeutics
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés